Beyond novel science

Beyond novel science

If we're lucky, Merck & Co.'s move last week to acquire Medco Containment Services Inc. for $6 billion will put an end to biotech road shows where CEOs proclaim their intention to build a "fully integrated pharmaceutical company."

Nobody knows that a fully integrated pharma company is going to be, and the whole idea dangerously distracts from the new thinking required to create companies that can acquire financing and provide a return for investors. The critical point is that the remapping of health care is unstoppable. President Clinton's

Read the full 910 word article

How to gain access

Continue reading with a
two-week free trial.